| RS868953385 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS868961188 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Inborn genetic diseases |
| RS868966337 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS868967798 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS868970795 |
WAS
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS868972342 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS868975952 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS868975969 |
RBP3
|
Health Risk |
Likely pathogenic |
— |
| RS868977191 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS868979094 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS868979288 |
PLS3
|
Health Risk |
Likely pathogenic |
— |
| RS868980404 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS868983143 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS868984500 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS868984872 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS868985177 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS868985556 |
KMT2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Wiedemann-Steiner syndrome |
| RS868985739 |
ATP1A3
|
Health Risk |
Likely pathogenic |
— |
| RS868988809 |
F8
|
Health Risk |
Pathogenic |
— |
| RS868990544 |
XK
|
Health Risk |
Pathogenic |
XK-related disorder, XK-related disorder |
| RS868991793 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KMT2A-related disorder |
| RS868992080 |
MTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS868993459 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS868993843 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS868995055 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS868996072 |
SSR4
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS869025175 |
KCNK18
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, with or without aura |
| RS869025176 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS869025177 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS869025178 |
EIF2AK3
|
Health Risk |
Pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS869025179 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS869025180 |
EYA1
|
Health Risk |
Pathogenic |
Otofaciocervical syndrome 1, Melnick-Fraser syndrome |
| RS869025181 |
GPC3
|
Health Risk |
Pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Simpson-Golabi-Behmel syndrome type 1 |
| RS869025182 |
GPC3
|
Health Risk |
Pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Thyroid cancer |
| RS869025183 |
GPC3
|
Health Risk |
Pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Simpson-Golabi-Behmel syndrome type 1 |
| RS869025184 |
ERCC4
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group F |
| RS869025185 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS869025188 |
NALCN
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS869025189 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome, Noonan syndrome 8 |
| RS869025191 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome, Noonan syndrome 8 |
| RS869025192 |
RIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, Neoplasm |
| RS869025193 |
RIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 8, Noonan syndrome |
| RS869025194 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome 8, Noonan syndrome |
| RS869025195 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome, Inborn genetic diseases |
| RS869025196 |
RIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, Noonan syndrome 8 |
| RS869025197 |
RIT1
|
Health Risk |
Pathogenic |
Noonan syndrome, Noonan syndrome 8 |
| RS869025198 |
FN1
|
Health Risk |
Pathogenic |
Glomerulopathy with fibronectin deposits 2, Glomerulopathy with fibronectin deposits 2 |
| RS869025199 |
FN1
|
Health Risk |
Pathogenic |
Glomerulopathy with fibronectin deposits 2, Glomerulopathy with fibronectin deposits 2 |
| RS869025200 |
CDK5RAP2
|
Health Risk |
Pathogenic |
Microcephaly 3, primary |
| RS869025201 |
LGI1
|
Health Risk |
Pathogenic |
Epilepsy, familial temporal lobe |
| RS869025202 |
FOXP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability |
| RS869025203 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, FOXP1-related disorder |
| RS869025204 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 1 |
| RS869025205 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS869025206 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 2, Retinitis pigmentosa 74 |
| RS869025207 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Retinal dystrophy |
| RS869025208 |
BBS9
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 9, Bardet-Biedl syndrome 9 |
| RS869025209 |
BBS10
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome 10 |
| RS869025210 |
BBS10
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome |
| RS869025211 |
BBS10
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome |
| RS869025212 |
BAP1
|
Health Risk |
Pathogenic |
BAP1 Cancer Syndrome, BAP1-related tumor predisposition syndrome |
| RS869025213 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS869025214 |
TRPM6
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS869025215 |
DVL3
|
Health Risk |
Pathogenic |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 3 |
| RS869025216 |
DVL3
|
Health Risk |
Pathogenic |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 3 |
| RS869025217 |
DVL3
|
Health Risk |
Likely pathogenic |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 3 |
| RS869025218 |
DVL3
|
Health Risk |
Pathogenic |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 3 |
| RS869025219 |
DVL3
|
Health Risk |
Pathogenic |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 3 |
| RS869025220 |
DVL1
|
Health Risk |
Pathogenic |
Autosomal dominant Robinow syndrome 2, Autosomal dominant Robinow syndrome 2 |
| RS869025221 |
RARB
|
Health Risk |
Likely pathogenic |
Microphthalmia, syndromic 12 |
| RS869025222 |
RARB
|
Health Risk |
Pathogenic/Likely pathogenic |
Microphthalmia, syndromic 12 |
| RS869025223 |
FKBP10
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 11, Osteogenesis imperfecta type 11 |
| RS869025224 |
ZAP70
|
Health Risk |
Pathogenic |
Combined immunodeficiency, Autoimmune disease |
| RS869025259 |
MITF
|
Health Risk |
Conflicting classifications of pathogenicity |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS869025262 |
DICER1
|
Health Risk |
Pathogenic |
Anophthalmia-microphthalmia syndrome, DICER1-related tumor predisposition |
| RS869025268 |
VSX2
|
Health Risk |
Pathogenic |
Anophthalmia-microphthalmia syndrome, Isolated microphthalmia 2 |
| RS869025269 |
STRA6
|
Health Risk |
Pathogenic |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS869025270 |
PTCH1
|
Health Risk |
Likely pathogenic |
Anophthalmia-microphthalmia syndrome, Anophthalmia-microphthalmia syndrome |
| RS869025271 |
TUBB8
|
Health Risk |
Pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS869025272 |
TUBB8
|
Health Risk |
Pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS869025273 |
TUBB8
|
Health Risk |
Pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS869025274 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis 2 |
| RS869025275 |
XPC
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum group A |
| RS869025276 |
CEP104
|
Health Risk |
Pathogenic |
Joubert syndrome 25, Joubert syndrome 25 |
| RS869025277 |
CEP104
|
Health Risk |
Pathogenic |
Joubert syndrome 25, Joubert syndrome 25 |
| RS869025278 |
CEP104
|
Health Risk |
Pathogenic |
Joubert syndrome 25, Joubert syndrome 25 |
| RS869025280 |
HACE1
|
Health Risk |
Pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS869025281 |
HACE1
|
Health Risk |
Pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS869025284 |
HACE1
|
Health Risk |
Pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS869025285 |
EPB41
|
Health Risk |
Pathogenic |
Hereditary elliptocytosis, Hereditary elliptocytosis |
| RS869025286 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Intellectual disability |
| RS869025287 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Intellectual disability |
| RS869025288 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS869025289 |
MED13L
|
Health Risk |
Pathogenic |
Impaired intellectual development and distinctive facial features with cardiac defects, Impaired intellectual development and distinctive facial features with cardiac defects |
| RS869025291 |
MED13L
|
Health Risk |
Pathogenic |
Impaired intellectual development and distinctive facial features with cardiac defects, Impaired intellectual development and distinctive facial features with cardiac defects |
| RS869025292 |
PMPCA
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 2, Autosomal recessive spinocerebellar ataxia 2 |
| RS869025293 |
PMPCA
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 2, Autosomal recessive spinocerebellar ataxia 2 |
| RS869025299 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS869025300 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS869025301 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |